Cargando…

Roles and Mechanisms of Astragaloside IV in Combating Neuronal Aging

Aging can lead to changes in the cellular milieu of the brain. These changes may exacerbate, resulting in pathological phenomena (including impaired bioenergetics, aberrant neurotransmission, compromised resilience and neuroplasticity, mitochondrial dysfunction, and the generation of free radicals)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zaman, Qumar, Zhang, Dahong, Reddy, Obireddy Sreekanth, Wong, Wing-Tak, Lai, Wing-Fu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JKL International LLC 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9662284/ https://www.ncbi.nlm.nih.gov/pubmed/36465185 http://dx.doi.org/10.14336/AD.2022.0126

Ejemplares similares

Cross-linked chitosan/lysozyme hydrogels with inherent antibacterial activity and tuneable drug release properties for cutaneous drug administration
por: Lai, Wing-Fu, et al.
Publicado: (2023)

A self-indicating and antibacterial gelatine–chitosan blended hydrogel enabling real-time quality control and sustained bioactive agent delivery
por: Lai, Wing-Fu, et al.
Publicado: (2023)

Multi-Component Hydrogel Beads Incorporated with Reduced Graphene Oxide for pH-Responsive and Controlled Co-Delivery of Multiple Agents
por: Obireddy, Sreekanth Reddy, et al.
Publicado: (2021)

ROS-Generating Amine-Functionalized Magnetic Nanoparticles Coupled with Carboxymethyl Chitosan for pH-Responsive Release of Doxorubicin
por: Obireddy, Sreekanth Reddy, et al.
Publicado: (2022)

Preparation and characterization of 2-hydroxyethyl starch microparticles for co-delivery of multiple bioactive agents
por: Obireddy, Sreekanth Reddy, et al.
Publicado: (2021)

ROS-generating, pH-responsive and highly tunable reduced graphene oxide-embedded microbeads showing intrinsic anticancer properties and multi-drug co-delivery capacity for combination cancer therapy
por: Boddu, Adilakshmi, et al.
Publicado: (2022)

Preparation and use of nanogels as carriers of drugs
por: Li, Cuixia, et al.
Publicado: (2021)

Anticancer effects and mechanisms of astragaloside-IV
por: Zhou, Liangxing, et al.
Publicado: (2022)

ROS-Generating Poly(Ethylene Glycol)-Conjugated Fe(3)O(4) Nanoparticles as Cancer-Targeting Sustained Release Carrier of Doxorubicin
por: Adilakshmi, Boddu, et al.
Publicado: (2022)

Preparation, Characterization and Dielectric Properties of Alginate-Based Composite Films Containing Lithium Silver Oxide Nanoparticles
por: Giriyappa Thimmaiah, Padma, et al.
Publicado: (2022)

The mechanism of astragaloside IV promoting sciatic nerve regeneration
por: Zhang, Xiaohong, et al.
Publicado: (2013)

Molecular mechanisms of astragaloside-IV in cancer therapy (Review)
por: Chen, Tianqi, et al.
Publicado: (2021)

Research progress on the mechanism of astragaloside IV in the treatment of asthma
por: Yuan, Fanyi, et al.
Publicado: (2023)

Review on the protective mechanism of astragaloside IV against cardiovascular diseases
por: Yang, Chunkun, et al.
Publicado: (2023)

Astragaloside IV combating liver cirrhosis through the PI3K/Akt/mTOR signaling pathway
por: Wei, Rendong, et al.
Publicado: (2019)

Effects of puerarin on the pharmacokinetics of astragaloside IV in rats and its potential mechanism
por: Zhang, Huan, et al.
Publicado: (2020)

Influence of astragaloside IV on pharmacokinetics of triptolide in rats and its potential mechanism
por: Gao, Jian, et al.
Publicado: (2020)

Effects of Astragaloside IV on heart failure in rats
por: Zhao, Zhuanyou, et al.
Publicado: (2009)

Effects of astragaloside IV on the pharmacokinetics of omeprazole in rats
por: Liu, Wei, et al.
Publicado: (2019)

Astragaloside IV, as a potential anticancer agent
por: Xia, Dongqin, et al.
Publicado: (2023)

Pharmacological Effects of Astragaloside IV: A Review
por: Liang, Yutong, et al.
Publicado: (2023)

Astragaloside IV for Experimental Focal Cerebral Ischemia: Preclinical Evidence and Possible Mechanisms
por: Wang, Hui-Lin, et al.
Publicado: (2017)

Network Pharmacology and Experimental Evidence Identify the Mechanism of Astragaloside IV in Oxaliplatin Neurotoxicity
por: Xu, Jingyu, et al.
Publicado: (2021)

Review of the pharmacological effects of astragaloside IV and its autophagic mechanism in association with inflammation
por: Yang, Ying, et al.
Publicado: (2022)

Astragaloside IV: An Effective Drug for the Treatment of Cardiovascular Diseases
por: Tan, Yu-Qing, et al.
Publicado: (2020)

In Vitro Neuroprotection of Rat Hippocampal Neurons by Manninotriose and Astragaloside IV Against Corticosterone-Induced Toxicity
por: Zheng, Jing, et al.
Publicado: (2018)

The role of Nrf2 in astragaloside IV-mediated antioxidative protection on heart failure
por: Sui, Yan-Bo, et al.
Publicado: (2020)

Preliminary study on the anti-apoptotic mechanism of Astragaloside IV on radiation-induced brain cells
por: Liu, Xin, et al.
Publicado: (2020)

Astragaloside IV ameliorates renal injury in db/db mice
por: Sun, Huili, et al.
Publicado: (2016)

Astragaloside IV inhibits astrocyte senescence: implication in Parkinson’s disease
por: Xia, Mei-Ling, et al.
Publicado: (2020)

Evaluation of astragaloside IV in hepatic fibrosis: A meta-analysis
por: Han, Zhongying, et al.
Publicado: (2021)

Astragaloside IV alleviates heart failure by modulating Nrf-2
por: Feng, Wenxiao, et al.
Publicado: (2022)

Pharmacokinetic study on the co-administration of abemaciclib and astragaloside IV in rats
por: Sun, Sen, et al.
Publicado: (2022)

Untapping the Potential of Astragaloside IV in the Battle Against Respiratory Diseases
por: Tan, Junlan, et al.
Publicado: (2023)

Astragaloside IV ameliorates fat metabolism in the liver of ageing mice through targeting mitochondrial activity
por: Luo, Zhixiao, et al.
Publicado: (2021)

Calcium Sensing Receptor-Related Pathway Contributes to Cardiac Injury and the Mechanism of Astragaloside IV on Cardioprotection
por: Lu, Meili, et al.
Publicado: (2018)

Molecular Mechanism of Astragaloside IV in Improving Endothelial Dysfunction of Cardiovascular Diseases Mediated by Oxidative Stress
por: Meng, Peipei, et al.
Publicado: (2021)

Astragalosidic Acid: A New Water-Soluble Derivative of Astragaloside IV Prepared Using Remarkably Simple TEMPO-Mediated Oxidation
por: Qing, Lin-Sen, et al.
Publicado: (2017)

Gastroprotective Effects of Astragaloside IV against Acute Gastric Lesion in Rats
por: Mao, Shuai, et al.
Publicado: (2016)

Protective Effects of Astragaloside IV on db/db Mice with Diabetic Retinopathy
por: Ding, Yuzhi, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_di4hvccuiah8giqcg2qtfs1tc6